Post by
tamaracktop on Aug 22, 2022 10:56am
It's too bad
It's too bad Xebec didn't provide a more comprehensive breakdown of the numbers in the Q1 release vis a vis the impact of the legacy issues on the quarterly numbers.
Then I'd have more numbers to crunch.
The more numbers the better.
As it stands, they did say the following in the notes to Q1.
"Adjusted EBITDA excluding legacy BGX activities of ($6.4) million compared to ($1.7) million."
In the Q2 release, this comment follows:
"Adjusted EBITDA (Non-IFRS) excluding legacy RNG contracts increased to a loss of $3.4 million for the three-month period ended June 30, 2022 from a loss of $0.9 million for the same period last year."
Xebec's sequential ebitda has gone from a loss of $6.4 million to a loss of $3.4 million.
The comparison mentioned in the notes referred to the numbers a year ago, and in that respect might be a bit misleading to those who gave the news a cursory glance.
Recent headcount reductions and the work-sharing program in Europe will further reduce costs by $1.25 million per quarter.
Xebec is very clearly on the road to profitability.
Any company showing this kind of revenue growth and demonstrating tangible margin improvement will have no problems whatsoever arranging financing.
When the news comes it will be a "revelation' for the market.
It will leave many players behind.
Xebec isn't a "show me story".
It's a "showing me story".
Comment by
Possibleidiot01 on Aug 22, 2022 4:32pm
HUH? Isn't this a worse result ? ""Adjusted EBITDA (Non-IFRS) excluding legacy RNG contracts increased to a loss of $3.4 million for the three-month period ended June 30, 2022 from a loss of $0.9 million for the same period last year." Am I living up to my name ?
Comment by
Possibleidiot01 on Aug 22, 2022 8:22pm
That sequential comparison was not positive unless you regard the first quarter under new management as a " kitchen sink" quarter?